Wird geladen...
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
Dapagliflozin belongs in the family of sodium-glucose cotransporter 2 (SGLT2) inhibitors and acts by reducing glucose reabsorption in the proximal tubule. The aim of this review is to present the differential pharmacology and clinical utility of dapagliflozin. Dapagliflozin is orally administered, h...
Gespeichert in:
| Veröffentlicht in: | Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6756826/ https://ncbi.nlm.nih.gov/pubmed/31572020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S172353 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|